Davis's Drug Guide
reteplase
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
re-te-plase
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Retavase
Ther. Class.
Pharm. Class.
plasminogen activators
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Reteplase." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109191/all/reteplase.
Vallerand AHA, Sanoski CAC. Reteplase. Davis's Drug Guide. F.A. Davis Company; 2026. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109191/all/reteplase. Accessed June 27, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Reteplase. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109191/all/reteplase
Vallerand AHA, Sanoski CAC. Reteplase [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 27]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109191/all/reteplase.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - reteplase
ID - 109191
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109191/all/reteplase
PB - F.A. Davis Company
ET - 20
DB - Anesthesia Central
DP - Unbound Medicine
ER -
